Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000873394 | SCV001015378 | likely benign | Tuberous sclerosis 2 | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001015908 | SCV001176799 | likely benign | Hereditary cancer-predisposing syndrome | 2018-01-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001712820 | SCV001940284 | likely benign | not provided | 2020-03-26 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000873394 | SCV002039213 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001015908 | SCV002531083 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-29 | criteria provided, single submitter | curation | |
Revvity Omics, |
RCV000873394 | SCV003821605 | uncertain significance | Tuberous sclerosis 2 | 2019-06-01 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004003087 | SCV004829053 | likely benign | Tuberous sclerosis syndrome | 2023-11-20 | criteria provided, single submitter | clinical testing |